Equity-Based Compensation (Tables)

3 Months Ended

Mar. 31, 2025

Share-Based Payment Arrangement [Abstract]

Summary of Compensation Cost Recognized

Presented below is a summary of the compensation cost recognized in the condensed consolidated statements of operations and comprehensive loss for the three months ended March 31, 2025 and 2024.

	Three Months Ended March 31,
(in thousands)	2025		2024
Research and development	$	699	$	1,231
Sales and marketing		-		75
General and administrative		1,390		2,060
Total	$	2,089	$	3,366

Summary of Stock Option Activity

The following summary sets forth the stock option activity under the 2023 and 2020 Plan:

	Number of options			Weighted average exercise price		Weighted average remaining contractual term (in years)		Aggregate intrinsic value (in thousands)
Outstanding as of December 31, 2024		796		$	10,154.03		8.3	$	—
Granted		—			—
Exercised		—			—
Cancelled or forfeited		(1	)		2,051.40
Outstanding as of March 31, 2025		795		$	10,160.08		8.0	$	—
Options exercisable as of March 31, 2025		452		$	4,749.08		7.9	$	—
Options unvested as of March 31, 2025		398		$	17,651.89		8.2	$	—